Tempe, Arizona – GT Medical Technologies has created a new way to target brain tumors like the type that took the late Senator John McCain’s life. GammaTile technology, invented and developed in Arizona, consists of four tiles implanted in a patient. These tiles contain dosages of radiation that targets glioblastomas. We’ll get more from Dr. David…

Tempe, Arizona –Listen to The Health Technology podcast from UCSF Rosenman Institute to hear GT Medical Technologies, Inc. CEO Matt Likens share how GammaTile Therapy challenges the current standard of care for patients with recurrent brain tumors by improving quality of life and delaying time to recurrence for all tumor pathologies (gliomas, meningiomas, metastases, etc.). LISTEN HERE

Tempe, Arizona & San Diego, California – BlueStone portfolio company GT Medical Technologies, Inc., a company dedicated to improving the lives of patients with brain tumors, today announced that Peter Nakaji, M.D., GT MedTech’s co-founder and director of the Neurosurgery Residency Program at Barrow Neurological Institute in Phoenix, has been selected by the American Association of Neurological…

Tempe, Arizona & Minneapolis, Minnesota –  University of Minnesota Health (M Health) is the first health system in the United States to begin offering GammaTile Therapy™, a new approach to treating recurrent brain tumors. GammaTile Therapy is an FDA-cleared, surgically targeted radiation therapy (STaRT™) that is designed to delay tumor regrowth for patients with brain tumors.…

Minneapolis, Minnesota –  It sounds like science fiction, but doctors at University of Minnesota Health are the first in the country to offer an implantable form of radiation to target brain cancer. The implant is called GammaTile Therapy and Linda Tinega was the first patient in Minnesota to receive it.  “Each tile, has four, radioactive seeds on…